December 11, 2025

Will Spatial Genomics Help Identify Barrett’s Esophagus Patients at High Risk of Esophageal Cancer?

A Keck Medicine of USC expert explains how next-generation genetic analysis could help stratify patients’ cancer risk — and guide treatment decisions.

Keck Medicine of USC

December 09, 2025

Armando E. Giuliano, MD, To Be Honored With 2025 William L. McGuire Memorial Lecture Award at SABCS

Armando E. Giuliano, MD, will receive the William L. McGuire Memorial Lecture Award during the 2025 San Antonio Breast Cancer Symposium (SABCS). Dr. Giuliano is being recognized for his pioneering wor...

The ASCO Post

December 09, 2025

AACI Issues Statement on Death of Dr. Ed Chu

The Association of American Cancer Institutes (AACI) offered a statement on the death of Dr. Ed Chu. Portions of that statement are provided here.

The ASCO Post

December 09, 2025

Rainer Storb, MD, Receives Distinguished Wallace H. Coulter Award at ASH Annual Congress

The American Society of Hematology (ASH) presented the Wallace H. Coulter Award for Lifetime Achievement in Hematology to Rainer Storb, MD, during the Society’s Annual Congress held in Orlando. Dr. St...

The ASCO Post

December 09, 2025

ASH Recognizes Leaders for Support of Patient Care and Research

The American Society of Hematology (ASH) will honor U.S. Senators Susan Collins (R-ME), Patty Murray (D-WA), Shelley Moore Capito (R-WV), and Tammy Baldwin (D-WI), as well as the patient groups Sick C...

The ASCO Post

December 09, 2025

Ross Levine, MD, Named Chief Scientific Officer of Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announced that Ross Levine, MD, has been named MSK’s new Chief Scientific Officer (CSO). Dr. Levine previously served as Senior Vice President of Translati...

The ASCO Post

December 09, 2025

Final Overall Survival Confirms Benefit of Durvalumab Plus FLOT in Resectable Gastric and Gastroesophageal Junction Adenocarcinomas

The addition of the PD-L1–targeting monoclonal antibody durvalumab to conventional perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) resulted in a statistical...

The ASCO Post

December 09, 2025

External Validation Confirms Ability of AI Model to Stratify Recurrence Risk in Early-Stage Lung Cancer

A machine learning–based survival model, incorporating preoperative CT images and routinely available clinical data, outperformed standard clinical staging systems in predicting recurrence after surge...

The ASCO Post

December 09, 2025

My 50 Years in Lymphoma: Lessons Learned?

In the 50 years now since my fellowship training, there have been major advances in the diagnosis, staging, prognostic scoring, treatment, and response assessment of lymphomas. To conjure up the futur...

The ASCO Post